AAAAAA

   
Results: 1-7 |
Results: 7
The effect of exogenous luteinizing hormone (LH) on oocyte viability: Evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproduction
Authors: Balasch, J Creus, M Fabregues, F Civico, S Carmona, F Puerto, B Casamitjana, R Vanrell, JA
Citation: J. Balasch et al., The effect of exogenous luteinizing hormone (LH) on oocyte viability: Evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproduction, J AS REPROD, 18(5), 2001, pp. 250-256
Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: A multivariate analysis
Authors: Carmona, F Font, J Azulay, M Creus, M Fabregues, F Cervera, R Puerto, B Balasch, J
Citation: F. Carmona et al., Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: A multivariate analysis, AM J REPROD, 46(4), 2001, pp. 274-279
Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modifiedstep-down regimens
Authors: Balasch, J Fabregues, F Creus, M Puerto, B Penarrubia, J Vanrell, JA
Citation: J. Balasch et al., Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modifiedstep-down regimens, HUM REPR, 16(4), 2001, pp. 652-656
Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: A prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol
Authors: Balasch, J Fabregues, F Creus, M Casamitjana, R Puerto, B Vanrell, JA
Citation: J. Balasch et al., Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: A prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol, J AS REPROD, 17(10), 2000, pp. 561-565
Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome
Authors: Fabregues, F Balasch, J Creus, M Carmona, F Puerto, B Quinto, L Casamitjana, R Vanrell, JA
Citation: F. Fabregues et al., Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome, J AS REPROD, 17(1), 2000, pp. 13-19
Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: Implications for implantation potential
Authors: Balasch, J Fabregues, F Creus, M Penarrubia, J Vidal, E Carmona, F Puerto, B Vanrell, JA
Citation: J. Balasch et al., Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: Implications for implantation potential, J AS REPROD, 17(1), 2000, pp. 20-27
Human chorionic gonadotrophin luteal support overcomes luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles
Authors: Penarrubia, J Balasch, J Fabregues, F Creus, M Casamitjana, R Ballesca, JL Puerto, B Vanrell, JA
Citation: J. Penarrubia et al., Human chorionic gonadotrophin luteal support overcomes luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles, HUM REPR, 13(12), 1998, pp. 3315-3318
Risultati: 1-7 |